A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function

Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating disease that progresses to right ventricular (RV) failure and death if left untreated. Little is known regarding the progression of RV failure in this disease, greatly limiting effective prognoses, and therapeutic interventions....

Full description

Bibliographic Details
Main Authors: Ashley Mulchrone, Heidi B. Kellihan, Omid Forouzan, Timothy A. Hacker, Melissa L. Bates, Christopher J. Francois, Naomi C. Chesler
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcvm.2018.00189/full
id doaj-1185bcdf92cb40acb20cd46fb2d351f0
record_format Article
spelling doaj-1185bcdf92cb40acb20cd46fb2d351f02020-11-25T00:46:27ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2019-01-01510.3389/fcvm.2018.00189432204A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on FunctionAshley Mulchrone0Heidi B. Kellihan1Omid Forouzan2Timothy A. Hacker3Melissa L. Bates4Melissa L. Bates5Christopher J. Francois6Naomi C. Chesler7Naomi C. Chesler8Department of Biomedical Engineering, Univeristy of Wisconsin-Madison, Madison, WI, United StatesSchool of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Biomedical Engineering, Univeristy of Wisconsin-Madison, Madison, WI, United StatesDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Health and Human Physiology, University of Iowa, Iowa City, IA, United StatesDepartment of Pediatrics, University of Iowa, Iowa City, IA, United StatesDepartment of Radiology, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Biomedical Engineering, Univeristy of Wisconsin-Madison, Madison, WI, United StatesDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, United StatesChronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating disease that progresses to right ventricular (RV) failure and death if left untreated. Little is known regarding the progression of RV failure in this disease, greatly limiting effective prognoses, and therapeutic interventions. Large animal models enable the use of clinical techniques and technologies to assess progression and diagnose failure, but the existing large animal models of CTEPH have not been shown to replicate the functional consequences of the RV, i.e., RV failure. Here, we created a canine embolization model of CTEPH utilizing only microsphere injections, and we used a combination of right heart catheterization (RHC), echocardiography (echo), and magnetic resonance imaging (MRI) to quantify RV function. Over the course of several months, CTEPH led to a 6-fold increase in pulmonary vascular resistance (PVR) in four adult, male beagles. As evidenced by decreased cardiac index (0.12 ± 0.01 v. 0.07 ± 0.01 [L/(min*kg)]; p < 0.05), ejection fraction (0.48 ± 0.02 v. 0.31 ± 0.02; p < 0.05), and ventricular-vascular coupling ratio (0.95 ± 0.09 v. 0.45 ± 0.05; p < 0.05), as well as decreased tricuspid annular plane systolic excursion (TAPSE) (1.37 ± 0.06 v. 0.86 ± 0.05 [cm]; p < 0.05) and increased end-diastolic volume index (2.73 ± 0.06 v. 2.98 ± 0.02 [mL/kg]; p < 0.05), the model caused RV failure. The ability of this large animal CTEPH model to replicate the hemodynamic consequences of the human disease suggests that it could be utilized for future studies to gain insight into the pathophysiology of CTEPH development, following further optimization.https://www.frontiersin.org/article/10.3389/fcvm.2018.00189/fullpulmonary embolizationpulmonary hemodynamicsright ventricular afterloadeffective arterial elastance (Ea)pulmonary vascular resistance (PVR)
collection DOAJ
language English
format Article
sources DOAJ
author Ashley Mulchrone
Heidi B. Kellihan
Omid Forouzan
Timothy A. Hacker
Melissa L. Bates
Melissa L. Bates
Christopher J. Francois
Naomi C. Chesler
Naomi C. Chesler
spellingShingle Ashley Mulchrone
Heidi B. Kellihan
Omid Forouzan
Timothy A. Hacker
Melissa L. Bates
Melissa L. Bates
Christopher J. Francois
Naomi C. Chesler
Naomi C. Chesler
A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function
Frontiers in Cardiovascular Medicine
pulmonary embolization
pulmonary hemodynamics
right ventricular afterload
effective arterial elastance (Ea)
pulmonary vascular resistance (PVR)
author_facet Ashley Mulchrone
Heidi B. Kellihan
Omid Forouzan
Timothy A. Hacker
Melissa L. Bates
Melissa L. Bates
Christopher J. Francois
Naomi C. Chesler
Naomi C. Chesler
author_sort Ashley Mulchrone
title A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function
title_short A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function
title_full A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function
title_fullStr A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function
title_full_unstemmed A Large Animal Model of Right Ventricular Failure due to Chronic Thromboembolic Pulmonary Hypertension: A Focus on Function
title_sort large animal model of right ventricular failure due to chronic thromboembolic pulmonary hypertension: a focus on function
publisher Frontiers Media S.A.
series Frontiers in Cardiovascular Medicine
issn 2297-055X
publishDate 2019-01-01
description Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating disease that progresses to right ventricular (RV) failure and death if left untreated. Little is known regarding the progression of RV failure in this disease, greatly limiting effective prognoses, and therapeutic interventions. Large animal models enable the use of clinical techniques and technologies to assess progression and diagnose failure, but the existing large animal models of CTEPH have not been shown to replicate the functional consequences of the RV, i.e., RV failure. Here, we created a canine embolization model of CTEPH utilizing only microsphere injections, and we used a combination of right heart catheterization (RHC), echocardiography (echo), and magnetic resonance imaging (MRI) to quantify RV function. Over the course of several months, CTEPH led to a 6-fold increase in pulmonary vascular resistance (PVR) in four adult, male beagles. As evidenced by decreased cardiac index (0.12 ± 0.01 v. 0.07 ± 0.01 [L/(min*kg)]; p < 0.05), ejection fraction (0.48 ± 0.02 v. 0.31 ± 0.02; p < 0.05), and ventricular-vascular coupling ratio (0.95 ± 0.09 v. 0.45 ± 0.05; p < 0.05), as well as decreased tricuspid annular plane systolic excursion (TAPSE) (1.37 ± 0.06 v. 0.86 ± 0.05 [cm]; p < 0.05) and increased end-diastolic volume index (2.73 ± 0.06 v. 2.98 ± 0.02 [mL/kg]; p < 0.05), the model caused RV failure. The ability of this large animal CTEPH model to replicate the hemodynamic consequences of the human disease suggests that it could be utilized for future studies to gain insight into the pathophysiology of CTEPH development, following further optimization.
topic pulmonary embolization
pulmonary hemodynamics
right ventricular afterload
effective arterial elastance (Ea)
pulmonary vascular resistance (PVR)
url https://www.frontiersin.org/article/10.3389/fcvm.2018.00189/full
work_keys_str_mv AT ashleymulchrone alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT heidibkellihan alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT omidforouzan alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT timothyahacker alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT melissalbates alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT melissalbates alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT christopherjfrancois alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT naomicchesler alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT naomicchesler alargeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT ashleymulchrone largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT heidibkellihan largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT omidforouzan largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT timothyahacker largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT melissalbates largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT melissalbates largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT christopherjfrancois largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT naomicchesler largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
AT naomicchesler largeanimalmodelofrightventricularfailureduetochronicthromboembolicpulmonaryhypertensionafocusonfunction
_version_ 1725265366830022656